Jan Brzezicki
- Rheumatology top 1%
- Immunology top 10%
- Hematology top 5%
- Genetics top 10%
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Gerd R BurmesterDésirée van der HeijdeR. B. M. LandewéPhilip J. MeaseRonald van VollenhovenMichael SchiffDavid MasonJosef S Smolen
- Topics
- Biosimilars and Bioanalytical Methods (6 papers)Pharmaceutical studies and practices (6 papers)Rheumatoid Arthritis Research and Therapies (4 papers)
- Cited by
- RheumatologyHematologyImmunology
- Journals
- SHILAP Revista de lepidopterologíaAnnals of the Rheumatic DiseasesJournal of the American Academy of Dermatology
- Partner nations
- PolandUnited StatesSouth Korea
In The Last Decade
Jan Brzezicki
11 papers receiving 869 citations
Peers
Comparison fields: 5 of 70
- Rheumatology 619
- Immunology 425
- Hematology 252
- Genetics 129
- Radiology, Nuclear Medicine and Imaging 107
Countries citing papers authored by Jan Brzezicki
This map shows the geographic impact of Jan Brzezicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Brzezicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Brzezicki more than expected).
Fields of papers citing papers by Jan Brzezicki
This network shows the impact of papers produced by Jan Brzezicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Brzezicki. The network helps show where Jan Brzezicki may publish in the future.
Co-authorship network of co-authors of Jan Brzezicki
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Brzezicki. A scholar is included among the top collaborators of Jan Brzezicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Brzezicki. Jan Brzezicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 137 | |
| 5 | 108 | |
| 6 | 144 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 17 | |
| 10 | 21 | |
| 11 | 399 | |
| 12 | Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial. | 67 |
About Jan Brzezicki
Jan Brzezicki is a scholar working on Rheumatology, Pediatrics, Perinatology and Child Health and Immunology, having authored 12 papers that have together received 909 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (6 papers), Pharmaceutical studies and practices (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). The work is most often cited by research in Rheumatology (619 citations), Hematology (252 citations) and Immunology (425 citations). Jan Brzezicki has collaborated with scholars based in Poland, United States and South Korea. Frequent co-authors include Gerd R Burmester, Désirée van der Heijde, R. B. M. Landewé, Philip J. Mease, Ronald van Vollenhoven, Michael Schiff, David Mason, Josef S Smolen, Jiří Vencovský and K. Luijtens. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.